PharmacoEconomics

Letter From the Commissioner's Office at the US FDA
pp. 89-90(2)
Author: Vernon, John A.

Is Medication Review by Pharmacists of Any Use?
pp. 91-92(2)
Authors: Zermansky, Arnold G.; Freemantle, Nick

Measuring Preferences for Cost-Utility Analysis: How Choice of Method May Influence Decision-Making
pp. 93-106(14)
Authors: McDonough, Christine M.; Tosteson, Anna N.A.

A `League Table' of Contingent Valuation Results for Pharmaceutical Interventions: A Hard Pill to Swallow?
pp. 107-127(21)
Authors: Sach, Tracey H.; Smith, Richard D.; Whynes, David K.

Disease Burden of Overactive Bladder: Quality-of-Life Data Assessed Using ICI-Recommended Instruments
pp. 129-142(14)
Authors: Basra, Ramandeep; Kelleher, Con

Conjoint Analysis of French and German Parents' Willingness to Pay for Meningococcal Vaccine
pp. 143-154(12)
Authors: Bishai, David; Brice, Roger; Girod, Isabelle; Saleh, Aneta; Ehreth, Jenifer

Acute/Subacute Herpes Zoster: Healthcare Resource Utilisation and Costs in a Group of US Health Plans
pp. 155-169(15)
Authors: Insinga, Ralph P.; Itzler, Robbin F.; Pellissier, James M.

Home-Based Medication Review in Older People: Is it Cost Effective?
pp. 171-180(10)
Authors: Pacini, Margaret; Smith, Richard D.; Wilson, Edward C.F.; Holland, Richard